Véronique Chotteau

Dr. Véronique Chotteau

1. Cell Technology, Department of Industrial Biotechnology, KTH-Royal Institute of Technology in Stockholm, 10691 Stockholm, Sweden
+1

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2013 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
MCMarie‐Françoise Clincke
Marie‐Françoise Clincke
CMCarin Mölleryd
Carin Mölleryd
YZYe Zhang
Ye Zhang
ELEva Lindskog
Eva Lindskog
KWKieron Walsh
Kieron Walsh
Véronique ChotteauVéronique Chotteau
Véronique Chotteau
High cell density perfusion process of antibody producing CHO cells was developed in disposable WAVE Bioreactor™ using external hollow fiber filter as cell separation device. Both “classical” tangential flow filtration (TFF) and alternating tangential flow system (ATF) equipment were used and compared. Consistency of both TFF‐ and ATF‐based cultures was shown at 20–35 × 106 cells/mL density stabilized by cell bleeds. To minimize the nutrients deprivation and by‐product accumulation, a perfusion rate correlated to the cell density was applied. The cells were maintained by cell bleeds at density 0.9–1.3 × 108 cells/mL in growing state and at high viability for more than 2 weeks. Finally, with the present settings, maximal cell densities of 2.14 × 108 cells/mL, achieved for the first time in a wave‐induced bioreactor, and 1.32 × 108 cells/mL were reached using TFF and ATF systems, respectively. Using TFF, the cell density was limited by the membrane capacity for the encountered high viscosity and by the pCO2 level. Using ATF, the cell density was limited by the vacuum capacity failing to pull the highly viscous fluid. Thus, the TFF system allowed reaching higher cell densities. The TFF inlet pressure was highly correlated to the viscosity leading to the development of a model of this pressure, which is a useful tool for hollow fiber design of TFF and ATF. At very high cell density, the viscosity introduced physical limitations. This led us to recommend cell densities under 1.46 × 108 cell/mL based on the analysis of the theoretical distance between the cells for the present cell line. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:754–767, 2013

22 February 2013 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
MCMarie‐Françoise Clincke
Marie‐Françoise Clincke
CMCarin Mölleryd
Carin Mölleryd
PSPuneeth K Samani
Puneeth K Samani
ELEva Lindskog
Eva Lindskog
EFEric Fäldt
Eric Fäldt
Véronique ChotteauVéronique Chotteau
Véronique Chotteau
A high cell density perfusion process of monoclonal antibody (MAb) producing Chinese hamster ovary (CHO) cells was developed in disposable WAVE Bioreactor™ using external hollow fiber (HF) filter as cell separation device. Tangential flow filtration (TFF) and alternating tangential flow (ATF) systems were compared and process applications of high cell density perfusion were studied here: MAb production and cryopreservation. Operations by perfusion using microfiltration (MF) or ultrafiltration (UF) with ATF or TFF and by fed‐batch were compared. Cell densities higher than 108 cells/mL were obtained using UF TFF or UF ATF. The cells produced comparable amounts of MAb in perfusion by ATF or TFF, MF or UF. MAbs were partially retained by the MF using ATF or TFF but more severely using TFF. Consequently, MAbs were lost when cell broth was discarded from the bioreactor in the daily bleeds. The MAb cell‐specific productivity was comparable at cell densities up to 1.3 × 108 cells/mL in perfusion and was comparable or lower in fed‐batch. After 12 days, six times more MAbs were harvested using perfusion by ATF or TFF with MF or UF, compared to fed‐batch and 28× more in a 1‐month perfusion at 108 cells/mL density. Pumping at a recirculation rate up to 2.75 L/min did not damage the cells with the present TFF settings with HF short circuited. Cell cryopreservation at 0.5 × 108 and 108 cells/mL was performed using cells from a perfusion run at 108 cells/mL density. Cell resuscitation was very successful, showing that this system was a reliable process for cell bank manufacturing. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:768–777, 2013

1 November 2020 in iScience
Verified
Journal Article
Open access
CZCaijuan Zhan
Caijuan Zhan
GBGholamreza Bidkhori
Gholamreza Bidkhori
HSHubert Schwarz
Hubert Schwarz
MMMagdalena Malm
Magdalena Malm
AMAman Mebrahtu
Aman Mebrahtu
Véronique ChotteauVéronique Chotteau
Véronique Chotteau
Human embryonic kidney cells HEK293 can be used for the production of therapeutic glycoproteins requiring human post-translational modifications. High cell density perfusion processes are advantageous for such production but are challenging due to the shear sensitivity of HEK293 cells. To understand the impact of hollow filter cell separation devices, cells were cultured in bioreactors operated with tangential flow filtration (TFF) or alternating tangential flow filtration (ATF) at various flow rates. The average theoretical velocity profile in these devices showed a lower shear stress for ATF by a factor 0.637 compared to TFF. This was experimentally validated and, furthermore, transcriptomic evaluation provided insights into the underlying cellular processes. High shear caused cellular stress leading to apoptosis by three pathways, i.e. endoplasmic reticulum stress, cytoskeleton reorganization, and extrinsic signaling pathways. Positive effects of mild shear stress were observed, with increased recombinant erythropoietin production and increased gene expression associated with transcription and protein phosphorylation.

1 February 2020 in Journal of Biotechnology
Verified
Journal Article
Closed access
HSHubert Schwarz
Hubert Schwarz
YZYe Zhang
Ye Zhang
CZCaijuan Zhan
Caijuan Zhan
MMMagdalena Malm
Magdalena Malm
RFRaymond Field
Raymond Field
Véronique ChotteauVéronique Chotteau
Véronique Chotteau

1 January 2019 in Chemical Engineering Science
Verified
Journal Article
Open access
CZCaijuan Zhan
Caijuan Zhan
EHErika Hagrot
Erika Hagrot
LBLuca Brandt
Luca Brandt
Véronique ChotteauVéronique Chotteau
Véronique Chotteau

31 March 2020 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
JGJoaquin Gomis-Fons
Joaquin Gomis-Fons
HSHubert Schwarz
Hubert Schwarz
LZLiang Zhang
Liang Zhang
NANiklas Andersson
Niklas Andersson
BNBernt Nilsson
Bernt Nilsson
Véronique ChotteauVéronique Chotteau
Véronique Chotteau
A continuous integrated bioprocess available from the earliest stages of process development allows for an easier, more efficient and faster development and characterization of an integrated process as well as production of small‐scale drug candidates. The process presented in this article is a proof‐of‐concept of a continuous end‐to‐end monoclonal antibody production platform at a very small scale based on a 200 ml alternating tangential flow filtration perfusion bioreactor, integrated with the purification process with a model‐based design and control. The downstream process, consisting of a periodic twin‐column protein A capture, a virus inactivation, a CEX column and an AEX column, was compactly implemented in a single chromatography system, with a purification time of less than 4 hr. Monoclonal antibodies were produced for 17 days in a high cell density perfusion culture of CHO cells with titers up to 1.0 mg/ml. A digital twin of the downstream process was created by modelling all the chromatography steps. These models were used for real‐time decision making by the implementation of control strategies to automatize and optimize the operation of the process. A consistent glycosylation pattern of the purified product was ensured by the steady state operation of the process. Regarding the removal of impurities, at least a 4‐log reduction in the HCP levels was achieved. The recovery yield was up to 60%, and a maximum productivity of 0.8 mg/ml/day of purified product was obtained.